Tuberculosis (TB) isn’t just something that happens ‘somewhere else’. It could affect you or someone you know.
The good news? TB is curable. Learn the signs to watch out for.
According to @brookenichols at #IAS2025, self-test-based PrEP continuation could offset the costs of bespoke programming for groups like MSM and female sex workers, allowing services to be maintained even amid funding cuts.
Ines Dourado from @UFBA and the Unitaid-funded PrEP-1519 project emphasizes that introducing self-testing is not just a technical fix: it’s a structural opportunity to simplify PrEP delivery, expand reach and reduce the clinical burden in overstretched health systems. #IAS2025
Christian Stillson of @CHAI_health reminds us: HIV self-testing has evolved from a diagnostic tool to a cornerstone of PrEP access. As we scale long-acting PrEP, self-testing will be critical to reaching more people, faster and more efficiently. #IAS2025
According to Dr. Lloyd Mulenga, self-testing isn’t just a backup, it's central to the future of HIV prevention. By embedding it in community settings and national guidelines, Zambia is shifting how prevention reaches those most at risk. #IAS2025
At #IAS2025, @WHO’s Michelle Rodolph highlighted the importance of long-acting injectable PrEP, such as lenacapavir, as an added option for HIV prevention. Expanding access to more methods gives people real choice and supports better health outcomes.
@WHO@WHO_Europe@WHOEMRO@WHOWPRO@WHOSEARO@WHOIndonesia@pahowho Great to see this out - critical to operationalize this using the WHO testing SOP to scale-up integrated testing for HIV and syphilis. Compelling results already coming out led by PNLS in DRC with just 3-months of implementation https://t.co/cNG6Jw3ScR
People living with HIV are at higher risk of severe #mpox. Knowing your HIV status and starting antiretroviral therapy is very important.
The new mpox guideline strongly recommends testing for HIV in people with mpox and starting antiretroviral therapy without delay.
🔗 https://t.co/zGeROZyy53
New guideline on the clinical management and infection prevention and control of #mpox.
This guidance is designed to support:
✅ Patients with mpox — whether at home, in the community, or in healthcare facilities
✅ The health workers and caregivers supporting them
Since the interim rapid response guidance in 2022, the mpox virus and outbreaks have continued to evolve.
This new guideline includes new and updated recommendations, grounded in the latest available evidence:
🔗 https://t.co/zGeROZyy53
This is the first of our three summary news bulletins from #CROI2025. The next one will be sent on Monday 17 March and the final one on Friday 21 March.
If you'd like to receive these bulletins as emails, and any future bulletins, sign up at: https://t.co/95PvQN1wMd
A great scientific signal towards another medical tool for #HIV prevention and protection.
@WHO's guidance for LEN PrEP twice-a-year dose is in development. If the trial for a yearly dose concludes successfully, WHO guidance will be rapidly adjusted.
https://t.co/7EURn2Iqtq
Since WHO recommended the global adoption of #HIV self-testing as a safe way to enhance access and uptake of testing, research indicates that self-testing can also ease #PrEP initiation and continuous usage. Explore this latest Review by Zhang and Co.
https://t.co/ROI3L3aErU
Women account for 67% of the health and care workforce and yet they are still paid 24% less on average than men working in the sector: https://t.co/1xbcli6wQU
This needs to end. #EqualPayDay